Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity

International Dairy Journal

Volumn 16, Issue 11, 2006, Pages 1277-1293

  Lopez Fandino R ^a   Otte, J ^b   van Camp, J ^c  

^a INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Angiotensin converting enzyme; Antihypertensive; Bioactive peptides; Bioavailability; Enrichment; Fermentation; Milk proteins; Proteolysis; Stability

Indexed keywords

DAIRY PRODUCTS; ENZYMES; FERMENTATION; HYDROLYSIS; MICROORGANISMS;

ANGIOTENSIN-CONVERTING ENZYME; ANTIHYPERTENSIVE; BIOACTIVE PEPTIDES; BIOAVAILABILITY; ENRICHMENT; MILK PROTEINS; PROTEOLYSIS;

POLYPEPTIDES;

EID: 33748297647     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2006.06.004     Document Type: Review

References (140)

1. Abubakar A., Saito T., Kitazawa H., Kawai Y., and Itoh T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. Journal of Dairy Science 81 (1998) 3131-3138
2. Ardö Y. Cheese ripening. General mechanisms and specific cheese varieties. Bulletin of the International Dairy Federation 369 (2001) 7-12
3. Awaisheh S.S., Haddadin M.S.Y., and Robinson R.K. Incorporation of selected nutraceuticals and probiotic bacteria into a fermented milk. International Dairy Journal 15 (2005) 1184-1190
4. Belitz H.-D., and Grosch W. Food chemistry. 2nd Ed (1999), Springer, Berlin, Germany pp. 257-267
5. Berger J., and Possompes B. Effects of severely alkali-treated casein on in vitro and in vivo digestibility and selected intestinal enzyme-activities. Nutrition Reports International 35 (1987) 69-78
6. Bouhallab S., Mollé D., and Léonil J. Continuous hydrolysis of β-casein in a membrane reactor: Preparation of a bioactive peptide. Biotechnology Letters 15 (1993) 697-702
7. Brew K. Structure of human ACE gives new insights into inhibitor binding and design. Trends in Pharmacological Sciences 24 (2003) 391-394
8. Broersen K., Voragen A.G.J., Hamer R.J., and de Jongh H.H.J. Glycoforms of β-lactoglobulin with improved thermostability and preserved structural packaging. Biotechnology and Bioengineering 86 (2004) 78-87
9. Coker C.J., Crawford R.A., Johnston K.A., Singh H., and Creamer L.K. Towards the classification of cheese varieties and maturity on the basis of statistical analysis of proteolytic data-A review. International Dairy Journal 15 (2005) 631-643
10. Crow V.L., Martley F.G., Coolbear T., and Roundhill S.J. The influence of phage-assisted lysis of Lactococcus lactis subsp. lactis M18 on cheddar cheese ripening. International Dairy Journal 5 (1995) 451-472
11. Curtis J.M., Dennis D., Waddell D.S., MacGillivray T., and Ewart H.S. Determination of angiotensin-converting enzyme inhibitory peptide Leu-Lys-Pro-Asn-Met (LKPNM) in Bonito muscle hydrolysates by LC-MS/MS. Journal of Agricultural and Food Chemistry 50 (2002) 3919-3925
12. Cushman D.W., and Cheung H.S. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochemical Pharmacology 20 (1971) 1637-1648
13. Damodaran S. Amino acids, peptides, and proteins. In: Fennema O.R. (Ed). Food chemistry. 3rd ed (1995), Marcel Dekker, Inc, New York, USA 321-430
14. Desai P., Coutinho E., and Srivastava S. Conformational diversity of T-kinin in DMSO, water and HFA. European Journal of Medicinal Chemistry 37 (2002) 135-146
15. Dziuba J., Iwaniak A., and Minkiewicz P. Computer-aided characteristics of proteins as potential precursors of bioactive peptides. Polimery 48 (2003) 50-53
16. FitzGerald R.J., and Meisel H. Lactokinins: Whey protein-derived ACE inhibitory peptides. Nahrung 43 (1999) 165-167
17. FitzGerald R.J., and Meisel H. Milk protein derived inhibitors of angiotensin-I-converting enzyme. British Journal of Nutrition 84 (2000) S33-S37
18. FitzGerald R.J., Murray B.A., and Walsh G.J. Hypotensive peptides from milk proteins. Journal of Nutrition 134 (2004) 980S-988S
19. Friedman M. Chemistry, nutrition and microbiology of d-amino acids. Journal of Agricultural and Food Chemistry 47 (1999) 3457-3479
20. Friedman M. Chemistry, biochemistry, nutrition, and microbiology of lysinoalanine, lanthionine, and histidinoalanine in food and other proteins. Journal of Agricultural and Food Chemistry 47 (1999) 1295-1319
21. Fuglsang A., Rattray F.P., Nilsson D., and Nyborg C.N. Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo. Journal of Enzyme Inhibition Medicinal Chemistry 18 (2003) 407-412
22. Fuglsang A., Rattray F.P., Nilsson D., and Nyborg C.N. Lactic acid bacteria: Inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie van Leeuwenhoek 83 (2003) 27-34
23. 1 receptor. Peptides 17 (1996) 635-639
24. Fujita H., and Yoshikawa M. LKPNM: A prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44 (1999) 123-127
25. Gatti M., Fornasari M.E., Lazzi C., Muncchetti G., and Neviani E. Peptidase activity in various species of dairy thermophilic lactobacilli. Journal of Applied Microbiology 96 (2004) 223-229
26. Gauthier S.F., and Pouliot Y. Functional and biological properties of peptides obtained by enzymatic hydrolysis of whey proteins. Journal of Dairy Science 86 (2003) E78-E87
27. Gilani G.S., and Sepehr E. Protein digestibility and quality in products containing antinutritional factors are adversely affected by old age in rats. Journal of Nutrition 133 (2003) 220-225
28. Gobetti M., Ferranti P., Smacchi E., Goffredi F., and Addeo F. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Applied and Environmental Microbiology 66 (2000) 3898-3904
29. Gobbetti M., Stepaniak L., De Angelis M., Corsetti A., and Cagno R.D. Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Critical Reviews in Food Science and Nutrition 42 (2002) 223-239
30. Gobetti M., Minervini F., and Grizzello C. Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. International Journal of Dairy Technology 57 (2004) 173-188
31. Gómez-Ruiz J.A., Ramos M., and Recio I. Angiotensin converting enzyme-inhibitory activity of peptides isolated from Manchego cheese. Stability under simulated gastrointestinal digestion. International Dairy Journal 14 (2004) 1075-1080
32. Gómez-Ruiz J.A., Ramos M., and Recio I. Identification and formation of angiotensin-converting enzyme-inhibitory peptides in Manchego cheese by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography A 1054 (2004) 269-277
33. Gómez-Ruiz J.A., Recio I., and Belloque J. ACE-inhibitory activity and structural properties of peptide Asp-Lys-Ile-His-Pro [β-CN f(47-51)]. Study of the peptide forms synthesized by different methods. Journal of Agricultural and Food Chemistry 52 (2004) 6315-6319
34. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., and Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 64 (1996) 767-771
35. Hernández-Ledesma B., Recio I., Ramos M., and Amigo L. Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin. International Dairy Journal 12 (2002) 805-812
36. Hernández-Ledesma B., Amigo L., Ramos M., and Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural and Food Chemistry 52 (2004) 1504-1510
37. Hernández-Ledesma B., Amigo L., Ramos M., and Recio I. Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas. International Dairy Journal 14 (2004) 889-898
38. Hernández-Ledesma B., Dávalos A., Bartolomé B., and Amigo L. Preparation of enzymatic hydrolysates from α-lactalbumin and β-lactoglobulin. Identification of active peptides by HPLC-MS/MS. Journal of Agricultural and Food Chemistry 53 (2005) 588-593
39. Hernández-Ledesma B., Miralles B., Amigo L., Ramos M., and Recio I. Identification of antioxidant and ACE-inhibitory peptides in fermented milk. Journal of the Science of Food and Agriculture 85 (2005) 1041-1048
40. Ijäs H., Collin M., Finckenberg P., Pihlanto-Leppälä A., Korhonen H., Korpela R., et al. Antihypertensive opioid-like milk peptide α-lactorphin: Lack of effect on behavioural test in mice. International Dairy Journal 14 (2004) 201-205
41. Jauhiainen T., Collin M., Narva M., Cheng Z.J., Poussa T., Vapaatalo H., et al. Effect of long-term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats. Milchwissenschaft 60 (2005) 358-363
42. I-type proteinase of Lactococcus lactis hydrolyses β-casein into more than one hundred different oligopeptides. Journal of Bacteriology 177 (1995) 3472-3478
43. Karaki H., Doi K., Sugano S., Uchiwa H., Sugai R., Murakami U., et al. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comparative Biochemistry and Physiology 96 part C (1990) 367-371
44. Khalid. N.M., Soda M.E., and Marth E.H. Peptide hydrolases of Lactobacillus helveticus and Lactobacillus delbrueckii ssp. bulgaricus. Journal of Dairy Science 74 (1991) 29-45
45. Knudsen J.C., Otte J., Olsen K., and Skibsted L.H. Effect of high hydrostatic pressure on the conformation of β-lactoglobulin A as assessed by proteolytic peptide profiling. International Dairy Journal 12 (2002) 791-803
46. Korhonen H., Pihlanto-Leppälä A., Rantamäki P., and Tupasela T. Impact of processing on bioactive proteins and peptides. Trends in Food Science and Technology 9 (1998) 307-319
47. Kunji E.R.S., Mierau I., Hagting A., Poolman B., and Konings W.N. The proteolytic systems of lactic acid bacteria. Antonie van Leeuwenhoek 70 (1996) 187-221
48. Kuono K., Hirano S., Kuboki H., Kasai M., and Hatae K. Effects of dried bonito (Katsuobushi) and captopril, an angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action. Bioscience Biotechnology and Biochemistry 69 (2005) 911-915
49. Lajoie N., Gauthier S.F., and Pouliot Y. Improved storage stability of model infant formula by whey peptide fractions. Journal of Agricultural and Food Chemistry 49 (2001) 1999-2007
50. Lapointe J.-F., Mollé D., Gauthier S.F., and Pouliot Y. Effect of calcium on thermolysin hydrolysis of β-casein tryptic peptides. International Dairy Journal 14 (2004) 185-193
51. Leclerc P.-L., Gauthier S.F., Bachelard H., Santure M., and Roy D. Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus. International Dairy Journal 12 (2002) 995-1004
52. Léonil J., Mollé D., Fauquant J., Maubois J.L., Pearce R.J., and Bouhallab S. Characterization by ionization mass spectrometry of lactosyl β-lactoglobulin conjugates formed during heat treatment of milk and whey and identification of one lactose-binding site. Journal of Dairy Science 80 (1997) 2270-2281
53. Li G.-H., Liu H., Shi Y.-H., and Le G.-W. Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. Journal of Pharmaceutical and Biomedical Analysis 37 (2005) 219-224
54. Lucas A., Sodini I., Monnet C., Jolivet P., and Corrieu G. Probiotic cell counts and acidification in fermented milks supplemented with milk protein hydrolysates. International Dairy Journal 14 (2004) 47-53
55. Lund M., and Ardö Y. Purification and identification of water-soluble phosphopeptides from cheese using Fe(III) affinity chromatography and mass spectrometry. Journal of Agricultural and Food Chemistry 52 (2004) 6616-6622
56. Lv G.S., Huo G.C., and Fu X.Y. Expression of milk-derived antihypertensive peptide in Escherichia coli. Journal of Dairy Science 86 (2003) 1927-1931
57. Maeno M., Yamamoto N., and Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. Journal of Dairy Science 79 (1996) 1316-1321
58. Maes W., Van Camp J., Vermeirssen V., Hemeryck M., Ketelslegers J.M., Schrezenmeir J., et al. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regulatory Peptides 118 (2004) 105-109
59. Manso M.A., and López-Fandiño R. Angiotensin I converting enzyme-inhibitory activity of bovine, ovine and caprine κ-casein macropeptides and their tryptic hydrolysates. Journal of Food Protection 66 (2003) 1686-1692
60. Martin-Orue C., Henry G., and Bouhallab S. Tryptic hydrolysis of κ-caseinomacropeptide: Control of the enzymatic reaction in a continous membrane reactor. Enzyme and Microbial Technology 24 (1999) 173-180
61. Maruyama S., Mitachi H., Awaya J., Kurono M., Tomizuka N., and Suzuki H. Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of αs1-casein. Agricultural and Biological Chemistry 51 (1987) 2557-2561
62. Masuda O., Nakamura Y., and Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. Journal of Nutrition 126 (1996) 3063-3068
63. Matoba N., Usui H., Fujita H., and Yoshikawa M. A novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Letters 452 (1999) 181-184
64. Matsui T., Imamura M., Oka H., Osajima K., Kimoto K.-I., Kawasaki T., et al. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its ingle oral administration to spontaneously hypertensive rats. Journal of Peptide Science 10 (2004) 535-545
65. Matsui T., Tamaya K., Seki E., Osajima K., Matsumoto K., and Kawasaki T. Absorption of Val-Tyr in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biological and Pharmaceutical Bulletin 25 (2002) 1228-1230
66. Matsuura K., Mizuno S., Nishimura S., Gotou T., and Yamamoto N. Quantitative analysis of the antihypertensive peptides Val-Pro-Pro and Ile-Pro-Pro in casein hydrolyzate using an Aspergillus oryzae protease: an LC-MS method. Milchwissenschaft 60 (2005) 24-27
67. Meisel H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 43 (1997) 119-128
68. Meisel H. Biochemical properties of bioactive peptides derived from milk proteins: Potential nutraceuticals for food and pharmaceutical applications. Livestock Production Science 50 (1997) 125-138
69. Meisel H. Multifunctional peptides encrypted in milk proteins. BioFactors 21 (2004) 55-61
70. Meisel H., Goepfert A., and Günther S. ACE-inhibitory activities in milk products. Milchwissenschaft 52 (1997) 307-311
71. Mestdagh F., De Meulenaer B., De Clippeleer J., Devlieghere F., and Huyghebaert A. Protective influence of several packaging materials on light-oxidation of milk. Journal of Dairy Science 88 (2005) 499-510
72. Miguel M., Muguerza B., Sánchez E., Delgado M.A., Recio I., Ramos M., et al. Long-term blood pressure-lowering effect of milk fermented by Enterococcus faecalis CECT 5728 in spontaneously hypertensive rats. British Journal of Nutrition 93 (2005) 1-9
73. Mizuno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. British Journal of Nutrition 94 (2005) 84-91
74. Mizuno S., Nishimura S., Matsuura K., Gotou T., and Yamamoto N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. Journal of Dairy Science 87 (2004) 3183-3188
75. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. American Journal of Hypertension 17 (2004) 701-706
76. Mollé D., Morgan F., Bouhallab S., and Léonil J. Selective detection of lactosylated peptides in hydrolysates by liquid chromatography/electrospray tandem mass spectrometry. Analytical Biochemistry 259 (1998) 152-161
77. Moutevelis-Minakakis P., Gianni M., Stougiannou H., Zoumpoulakis P., Zoga A., Vlahakos A.D., et al. Design and synthesis of novel antihypertensive drugs. Bioorganic & Medicinal Chemistry Letters 13 (2003) 1737-1740
78. Muguerza B., Ramos M., Sánchez E., Manso M.A., Miguel M., Aleixandre A., et al. Antihypertensive activity of milks fermented by Enterococcus faecalis strains isolated from raw milk. International Dairy Journal 16 (2006) 61-69
79. Mullally M.M., Meisel H., and FitzGerald R.J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Letters 402 (1997) 99-101
80. Mullally M.M., Meisel H., and Fitzgerald R.J. Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins. International Dairy Journal 7 (1997) 299-303
81. Murakami M., Tonouchi H., Takahashi R., Kitazawa H., Kawai Y., Negishi H., et al. Structural analysis of a new anti-hypertensive peptide (β-lactosin B) isolated from a commercial whey product. Journal of Dairy Science 87 (2004) 1967-1974
82. Murray B.A., Walsh D.J., and FitzGerald R.J. Modification of the furanacryloyl-l-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity. Journal of Biochemical and Biophysical Methods 59 (2004) 127-137
83. Nakamura Y., Masuda O., and Takano T. Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Bioscience, Biotechechnology and Biochemistry 60 (1996) 488-489
84. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., and Takano T. Purification and characterization of angiotensin-I-converting enzyme inhibitors from a sour milk. Journal of Dairy Science 78 (1995) 777-783
85. Nakamura Y., Yamamoto N., Sakai K., and Takano T. Antihypertensive effect of sour milk and peptides isolated from it a that are inhibitors to angiotensin-I-converting enzyme. Journal of Dairy Science 78 (1995) 1253-1257
86. Narva M., Halleen J., Vaanamen K., and Korpela R. Effects of Lactobacillus helveticus fermented milk on bone cells in vitro. Life Sciences 75 (2004) 1727-1734
87. Natesh R., Schwager S.L.U., Sturrock E.D., and Acharaya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421 (2003) 551-554
88. Noiseux I., Gauthier S.F., and Turgeon S.L. Interactions between bovine β-lactoglobulin and peptides under different physicochemical conditions. Journal of Agricultural and Food Chemistry 50 (2002) 1587-1592
89. Nurminen M.-L., Korpela R., and Vapaatalo H. Dietary factors in the pathogenesis and treatment of hypertension. Annals of Medicine 30 (1998) 143-150
90. Nurminen M.-L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., et al. α-lactorphin lowers blood pressure measured by radiotelementry in normotensive and spontaneously hypertensive rats. Life Sciences 66 (2000) 1535-1543
91. Pao Y.-L., Wormarld M.R., Raymond A.D., and Lellouch A.C. Effect of serine O-glycosylation on cis-trans proline isomerisation. Biochemical and Biophysical Research Communications 219 (1996) 157-162
92. Pihlanto-Leppälä A. Bioactive peptides derived from bovine whey proteins: Opioid and ACE-inhibitory peptides. Trends in Food Science and Technology 11 (2001) 347-356
93. Pihlanto-Leppälä A., Koskinen P., Piilola K., Tupasela T., and Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. Journal of Dairy Research 67 (2000) 53-64
94. Pihlanto-Leppälä A., Rokka T., and Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal 8 (1998) 325-331
95. Pins J.J., and Keenan J.M. The antihypertensive effects of a hydrolyzed whey protein isolate supplement (Biozate 1): A pilot study. FASEB Journal 17 Suppl. (2003) A1110
96. Pripp A.H., Isaksson T., Stepaniak L., and Sorhaug T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. European Food Research and Technology 219 (2004) 579-583
97. Pripp H.A. Initial proteolysis of milk proteins and its effect on formation of ACE-inhibitory peptides during gastrointestinal proteolysis: A bioinformatic, in silico, approach. European Food Research and Technology 221 (2005) 712-716
98. Pritchard G.G., and Coolbear T. The physiology and biochemistry of the proteolytic system in lactic acid bacteria. FEMS Microbiology Reviews 12 (1993) 179-206
99. Quirós, A., Ramos, M., Muguerza, B., Delgado, M. A., Miguel, M., Aleixandre, A., et al. (2006). Identification of novel antihypertensive peptides in milk fermented with Enterococus faecalis. International Dairy Journal, in press, doi:10.1016/j.idairyj.2005.12.011.
100. Rérat A., Calmes R., Vaissade P., and Finot P.-A. Nutritional and metabolic consequences of the early Maillard reaction of heat treated milk in pig. European Journal of Nutrition 41 (2002) 1-11
101. Rickert K.W., and Imperiali B. Analysis of the conserved glycosylation site in the nicotinic acetylcholine-receptor-potential roles in complex assembly. Chemistry & Biology 2 (1995) 751-775
102. Righetti P.G., Nembri F., Bossi A., and Mortarino M. Continous enzymatic hydrolysis of β-casein and isoelectric collection of some of the biologically active peptides in an electric field. Biotechnology Progress 13 (1997) 258-264
103. Rival S.G., Boeriu C.G., and Wichers H.J. Caseins and casein hydrolyzates. 2. Antioxidant properties and relevance to lipoxygenase inhibition. Journal of Agricultural and Food Chemisty 49 (2001) 295-302
104. Robert M.-C., Razaname A., Mutter M., and Juillerat M.A. Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765. Journal of Agricultural and Food Chemistry 52 (2004) 6923-6931
105. Rokka T., Syväoja E.-L., Tuominen J., and Korhonen H. Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk. Milchwissenschaft 52 (1997) 675-678
106. Roufik S., Gauthier S.F., and Turgeon S.L. In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. International Dairy Journal 16 (2006) 294-302
107. Ryhänen E.-L., Pihlanto-Leppälä A., and Pahkala E. A new type of ripened, low-fat cheese with bioactive properties. International Dairy Journal 11 (2001) 441-447
108. Saito T., Abubakar A., Itoh T., Arai I., and Aimar M.V. Development of a new type of fermented cheese whey beverage with inhibitory effects against angiotensin-converting enzyme. Tohoku Journal of Agricultural Research 48 (1997) 15-23
109. Saito T., Nakamura T., Kitazawa H., Kawai Y., and Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in gouda cheese. Journal of Dairy Science 83 (2000) 1434-1440
110. Sasaki. M., Bosman B.W., and Tan P.S.T. Comparison of proteolytic activities in various lactobacilli. Journal of Dairy Research 62 (1995) 601-610
111. Satake M., Enjoh M., Nakamura Y., Takano T., Kawamura Y., Arai S., et al. Transepithelial transport of the bioactive tripeptide Val-Pro-Pro in human intestinal Caco-2 cell monolayers. Bioscience, Biotechnology and Biochemistry 66 (2002) 378-384
112. Schlothauer, R.-C., Schollum, L.M., Reid, J.R., Harvey, S.A., Carr, A., & Fanshawe, R.L. (2002). Improved bioactive whey protein hydrolysate. PCT/NZ01/00188(WO 02/19837 A1). New Zealand.
113. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 77 (2003) 326-330
114. Seppo L., Kerojoki O., Suomalainen T., and Korpela R. The effect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension: A pilot study on humans. Milchwissenschaft 57 (2002) 124-127
115. Shalaby, S.M., Zakora, M., & Otte, J. (2006). Performance of two commonly used Angiotensin-converting enzyme inhibition assays using synthetic peptide substrates. Journal of Dairy Research, in press.
116. Shimizu M., Tsunogai M., and Arai S. Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 18 (1997) 681-687
117. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., and Nurminen M.-L. Effect of long-term intake of milk products on blood pressure in hypertensive rats. Journal of Dairy Research 69 (2002) 103-111
118. Sipola M., Finckenberg P., Vapaatalo H., Pihlanto-Leppälä A., Korhonen H., Korpela R., et al. α-lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sciences 71 (2002) 1245-1253
119. Smacchi E., and Gobbetti M. Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme and Microbial Technology 22 (1998) 687-694
120. Steijns J. Dietary proteins as the source of new healthy promoting bio-active peptides with special attention to glutamine peptide. Food Technolgy Europe 3 (1996) 80-84
121. Sugai R. ACE inhibitors and functionl foods. Bulletin of the IDF 336 (1998) 17-20
122. s2-casein. FEBS Letters 531 (2002) 369-374
123. Touyz R.M. Reactive oxygen species, vascular oxidative stress and redox signaling in hypertension: what is the clinical significance?. Hypertension 44 (2004) 248-252
124. Townsend R.R., McFadden C.B., Ford V., and Cadée J.A. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysaet (C12 peptide) in human essential hypertension. American Journal of Hypertension 17 (2004) 1056-1058
125. Tuomilehto J., Lindstrom J., Hyyrynen J., Korpela R., Karhunen M.L., Mikkola L., et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with milk hypertension. Journal of Human Hypertension 18 (2004) 795-802
126. Turgeon S.L., Gauthier S.F., Mollé D., and Léonil J. Interfacial properties of tryptic peptides of β-Lactoglobulin. Journal of Agricultural and Food Chemistry 40 (1992) 669-675
127. Valence F., Deutsch S.M., Richoux R., Gagnaire V., and Lortal S. Autolysis and related proteolysis in Swiss cheese for two Lactobacillus helveticus strains. Journal of Dairy Research 67 (2000) 261-271
128. van Elswijk D.A., Diefenbach O., van der Berg S., Irth H., Tjaden U.R., and Van Der Greef J. Rapid detection and identification of angiotensin-converting enzyme inhibitors by on-line liquid chromatography-biochemical detection, coupled to electrospray mass spectrometry. Journal of Chromatography A 1020 (2003) 45-58
129. Vercruysse L., Smagghe G., Herregods G., and Van Camp J. ACE inhibitory activity in enzymatic hydrolysates of insect protein. Journal of Agricultural and Food Chemistry 53 (2005) 5207-5211
130. Vermeirssen V., Deplancke B., Tappenden K.A., Van Camp J., Gaskins H.R., and Verstraete W. Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer. Journal of Peptide Science 8 (2002) 95-100
131. Vermeirssen V., Van Camp J., and Verstraete W. Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides. Journal of Biochemical and Biophysical Methods 51 (2002) 75-87
132. Vermeirssen V., Van Camp J., Decroos K., Van Wijmelbeke V., and Verstraete W. The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein. Journal of Dairy Science 86 (2003) 429-438
133. Vermeirssen V., Van Camp J., Devos L., and Verstraete W. Release of Angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semicontinuous model. Journal of Agricultural and Food Chemistry 51 (2003) 5680-5687
134. Vermeirssen V., Van Camp J., and Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 92 (2004) 357-366
135. Vermeirssen V., van der Bent A., Van Camp J., van Amerongen A., and Verstraete W. A quantitative in silico analysis calculates the angiotensin I converting enzyme (ACE) inhibitory activity in pea and whey protein digests. Biochimie 86 (2004) 213-239
136. Walsh D.J., Bernard H., Murray B.A., MacDonald J., Pentzien A.-K., Wright G.A., et al. In vitro generation and stability of the lactokinin β-lactoglobulin fragment (142-148). Journal of Dairy Science 87 (2004) 3845-3857
137. Yamada Y., Matoba N., Usui H., Onishi K., and Yoshikawa M. Design of a highly potent anti-hypertensive peptide based on ovokinin(2-7). Bioscience, Biotechnology and Biochemistry 66 (2002) 1213-1217
138. Yamamoto N., Akino A., and Takano T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactocobacillus helveticus CP790. Journal of Dairy Science 77 (1994) 917-922
139. Yamamoto N., Maeno M., and Takano T. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. Journal of Dairy Science 82 (1999) 1388-1393
140. Yamamoto N., and Takano T. Antihypertensive peptides derived from milk proteins. Nahrung 43 (1999) 159-164